|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/20 | |
| A61K 31/4523 | |||
| A61K 31/45 | |||
| A61K 31/451 | |||
| A61P 25/06 |
| (11) | Number of the document | 2846798 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13788067.0 |
| Date of filing the European patent application | 2013-05-03 | |
| (97) | Date of publication of the European application | 2015-03-18 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/039373 |
| Date | 2013-05-03 |
| (87) | Number | WO 2013/169574 |
| Date | 2013-11-14 |
| (30) | Number | Date | Country code |
| 201261644628 P | 2012-05-09 | US |
| (72) |
BELL, Ian, M., US
FRALEY, Mark, US
BIFTU, Tesfaye, US
ZHU, Cheng, US
NAIR, Anilkumar, US
MITCHELL, Helen, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ALIPHATIC SPIROLACTAM CGRP RECEPTOR ANTAGONISTS |
| ALIPHATIC SPIROLACTAM CGRP RECEPTOR ANTAGONISTS |